Physician profile

Shen Ling

Periodontics · Torrance, CA

NPI 1003029927

$619.10

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$70.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Orapharma, A Division of Bausch Health US, LLC $164.75 2019-2024 Ossix Plus, Arestin
Nobel Biocare USA $104.53 2019-2023 Nobelactive
Purelife, LLC $100.00 2019-2020
Salvin Dental Specialties, INC. $64.07 2019-2020
Hu-Friedy Mfg. Co., LLC $60.00 2020
Ace Surgical Supply Co., INC. $42.07 2020
Biohorizons Implant Systems INC. $41.30 2024 Biohorizons
Zimmer Biomet Holdings, INC. $27.85 2019
Gc America INC. $14.53 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shen Ling

$619.10

in general payments reported 2019-2025

Years
2019-2024
Top company
Orapharma, A Division of Bausch Health US, LLC

https://glasscript.com/doctor/45233/shen-ling

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.